Search by Drug Name or NDC
NDC 69097-0072-12 Bupropion Hydrochloride 300 mg/1 Details
Bupropion Hydrochloride 300 mg/1
Bupropion Hydrochloride is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cipla USA., Inc.. The primary component is BUPROPION HYDROCHLORIDE.
MedlinePlus Drug Summary
Bupropion (Aplenzin, Wellbutrin, Wellbutrin SR, Wellbutrin XL) is used to treat depression. Bupropion (Aplenzin, Wellbutrin XL) is also used to treat seasonal affective disorder (SAD; episodes of depression that occur at the same time each year [usually in the fall and winter but rarely may occur in the spring or summer months]). Bupropion (Zyban) is used to help people stop smoking. Bupropion is in a class of medications called antidepressants. It works by increasing certain types of activity in the brain.
Related Packages: 69097-0072-12Last Updated: 05/05/2024
MedLinePlus Full Drug Details: Bupropion
Product Information
| NDC | 69097-0072 |
|---|---|
| Product ID | 69097-072_9c292b5a-2a09-4f01-b1fe-8652dd577542 |
| Associated GPIs | |
| GCN Sequence Number | 053007 |
| GCN Sequence Number Description | bupropion HCl TAB ER 24H 300 MG ORAL |
| HIC3 | H7D |
| HIC3 Description | NOREPINEPHRINE AND DOPAMINE REUPTAKE INHIB (NDRIS) |
| GCN | 20318 |
| HICL Sequence Number | 001653 |
| HICL Sequence Number Description | BUPROPION HCL |
| Brand/Generic | Generic |
| Proprietary Name | Bupropion Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Bupropion hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 300 |
| Active Ingredient Units | mg/1 |
| Substance Name | BUPROPION HYDROCHLORIDE |
| Labeler Name | Cipla USA., Inc. |
| Pharmaceutical Class | Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA207479 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69097-0072-12 (69097007212)
| NDC Package Code | 69097-072-12 |
|---|---|
| Billing NDC | 69097007212 |
| Package | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69097-072-12) |
| Marketing Start Date | 2023-10-25 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.14428 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | BUPROPION HCL XL 300 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis